These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21876190)

  • 1. Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and C.
    Ikeda H; Tateishi R; Enooku K; Yoshida H; Nakagawa H; Masuzaki R; Kondo Y; Goto T; Shiina S; Kume Y; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Ono T; Koike K; Yatomi Y
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2204-11. PubMed ID: 21876190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Aspartate Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study.
    Zhang C; Wu J; Xu J; Xu J; Xian J; Xue S; Ye J
    Dis Markers; 2019; 2019():2046825. PubMed ID: 31814857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads.
    Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
    Ann Surg Oncol; 2015 Mar; 22(3):843-50. PubMed ID: 25269529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
    Jeng JE; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(2):637-42. PubMed ID: 24568470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
    Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
    J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
    Li X; Xu H; Gao P
    Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis.
    Uemura M; Fujimura Y; Matsumoto M; Ishizashi H; Kato S; Matsuyama T; Isonishi A; Ishikawa M; Yagita M; Morioka C; Yoshiji H; Tsujimoto T; Kurumatani N; Fukui H
    Thromb Haemost; 2008 Jun; 99(6):1019-29. PubMed ID: 18521503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
    Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
    Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ito K; Arai M; Imazeki F; Yonemitsu Y; Bekku D; Kanda T; Fujiwara K; Fukai K; Sato K; Itoga S; Nomura F; Yokosuka O
    Scand J Gastroenterol; 2010; 45(2):243-9. PubMed ID: 20095888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.
    Maki A; Kono H; Gupta M; Asakawa M; Suzuki T; Matsuda M; Fujii H; Rusyn I
    Ann Surg Oncol; 2007 Mar; 14(3):1182-90. PubMed ID: 17195915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection.
    Shen SL; Fu SJ; Chen B; Kuang M; Li SQ; Hua YP; Liang LJ; Guo P; Hao Y; Peng BG
    Ann Surg Oncol; 2014 Nov; 21(12):3802-9. PubMed ID: 24849520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
    Wu JC; Huang YH; Chau GY; Su CW; Lai CR; Lee PC; Huo TI; Sheen IJ; Lee SD; Lui WY
    J Hepatol; 2009 Nov; 51(5):890-7. PubMed ID: 19747749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer.
    Park YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Han S; Jeon MY; Heo JY; Song K; Kim SU
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1221-1229. PubMed ID: 27859587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
    Nabih MI; Aref WM; Fathy MM
    Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.